Suppr超能文献

阿尔茨海默病患者住院后出现不良结局和谵妄。

Adverse outcomes after hospitalization and delirium in persons with Alzheimer disease.

机构信息

Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife, 1200 Centre Street, Boston, MA 02131, USA.

出版信息

Ann Intern Med. 2012 Jun 19;156(12):848-56, W296. doi: 10.7326/0003-4819-156-12-201206190-00005.

Abstract

BACKGROUND

Hospitalization, frequently complicated by delirium, can be a life-changing event for patients with Alzheimer disease (AD).

OBJECTIVE

To determine risks for institutionalization, cognitive decline, or death associated with hospitalization and delirium in patients with AD.

DESIGN

Prospective cohort enrolled between 1991 and 2006 into the Massachusetts Alzheimer's Disease Research Center (MADRC) patient registry.

SETTING

Community-based.

PARTICIPANTS

771 persons aged 65 years or older with a clinical diagnosis of AD.

MEASUREMENTS

Hospitalization, delirium, death, and institutionalization were identified through administrative databases. Cognitive decline was defined as a decrease of 4 or more points on the Blessed Information-Memory-Concentration test score. Multivariate analysis was used to calculate adjusted relative risks (RRs).

RESULTS

Of 771 participants with AD, 367 (48%) were hospitalized and 194 (25%) developed delirium. Hospitalized patients who did not have delirium had an increased risk for death (adjusted RR, 4.7 [95% CI, 1.9 to 11.6]) and institutionalization (adjusted RR, 6.9 [CI, 4.0 to 11.7]). With delirium, risk for death (adjusted RR, 5.4 [CI, 2.3 to 12.5]) and institutionalization (adjusted RR, 9.3 [CI, 5.5 to 15.7]) increased further. With hospitalization and delirium, the adjusted RR for cognitive decline for patients with AD was 1.6 (CI, 1.2 to 2.3). Among hospitalized patients with AD, 21% of the incidences of cognitive decline, 15% of institutionalization, and 6% of deaths were associated with delirium.

LIMITATIONS

Cognitive outcome was missing in 291 patients. Sensitivity analysis was performed to test the effect of missing data, and a composite outcome was used to decrease the effect of missing data.

CONCLUSION

Approximately 1 in 8 hospitalized patients with AD who develop delirium will have at least 1 adverse outcome, including death, institutionalization, or cognitive decline, associated with delirium. Delirium prevention may represent an important strategy for reducing adverse outcomes in this population.

摘要

背景

住院治疗常常会并发谵妄,这可能会使阿尔茨海默病(AD)患者的生活发生改变。

目的

确定与 AD 患者住院和谵妄相关的住院治疗、认知能力下降或死亡的风险因素。

设计

前瞻性队列研究,1991 年至 2006 年期间纳入马萨诸塞州阿尔茨海默病研究中心(MADRC)患者登记处。

地点

社区。

参与者

771 名年龄在 65 岁及以上、临床诊断为 AD 的患者。

测量方法

通过行政数据库确定住院治疗、谵妄、死亡和住院治疗情况。认知能力下降定义为Blessed 信息记忆浓度测试评分下降 4 分或 4 分以上。采用多变量分析计算调整后的相对风险(RR)。

结果

771 名 AD 患者中,367 名(48%)住院治疗,194 名(25%)发生谵妄。未发生谵妄的住院患者死亡风险增加(调整 RR,4.7 [95%CI,1.9 至 11.6])和住院治疗风险增加(调整 RR,6.9 [CI,4.0 至 11.7])。发生谵妄后,死亡风险(调整 RR,5.4 [CI,2.3 至 12.5])和住院治疗风险(调整 RR,9.3 [CI,5.5 至 15.7])进一步增加。AD 患者发生住院治疗和谵妄时,认知能力下降的调整 RR 为 1.6(CI,1.2 至 2.3)。在住院 AD 患者中,21%的认知能力下降发生率、15%的住院治疗发生率和 6%的死亡率与谵妄有关。

局限性

771 名患者中有 291 名患者的认知结果缺失。进行了敏感性分析以测试缺失数据的影响,并使用综合结果来降低缺失数据的影响。

结论

大约每 8 名住院治疗的 AD 患者中就有 1 名患者发生谵妄,谵妄至少会导致 1 种不良结局,包括死亡、住院治疗或认知能力下降,与谵妄相关。谵妄预防可能是减少该人群不良结局的重要策略。

相似文献

7
Impact of delirium on the course of Alzheimer disease.谵妄对阿尔茨海默病病程的影响。
Arch Neurol. 2012 Dec;69(12):1639-40. doi: 10.1001/archneurol.2012.2703.
8
Delirium and Long-term Cognitive Trajectory Among Persons With Dementia.痴呆症患者的谵妄与长期认知轨迹
Arch Intern Med. 2012 Sep 24;172(17):1324-31. doi: 10.1001/archinternmed.2012.3203.

引用本文的文献

4
The Relationship between Delirium and Dementia.谵妄与痴呆的关系。
Semin Neurol. 2024 Dec;44(6):732-751. doi: 10.1055/s-0044-1791543. Epub 2024 Oct 11.

本文引用的文献

4
Analysis of large databases in vascular surgery.血管外科学大数据库分析。
J Vasc Surg. 2010 Sep;52(3):768-74. doi: 10.1016/j.jvs.2010.03.027.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验